September 03, 2014
Ultragenyx Announces Positive Interim Data From Phase 1/2 Study of Recombinant Human Beta-Glucuronidase in Mucopolysaccharidosis 7
Media
September 01, 2014
MIPS + BRG SPORTS
August 29, 2014
Orexo has successfully completed its private placement of approx. SEK 346.5m
August 29, 2014
Onxeo strengthens Beleodaq™ patent protection in the U.S. until 2027
August 29, 2014
Nordic Nanovector – Approved prospectus
August 28, 2014
Nexstim Progresses its Navigated Brain Stimulation Technology in Stroke and Demonstrates Improved Outcomes in Brain Tumor Surgery
August 26, 2014
Nordic Nanovector AS: Second Quarter Report 2014
August 26, 2014
Nordic Nanovector AS: The Board appoints Mr. Luigi Costa as new CEO
August 26, 2014
MIPS Adds New Brand Partners and New Models in 2015
August 20, 2014
Orexo enhances commercial focus and operating efficiencies